Stroke is a leading cause of death and disability, especially in certain ethnic groups. Impaired consciousness is a common outcome in stroke patients, serving as a predictor of prognosis and mortality. Lately, there has been increased interest in drugs such as Levodopa (LD), which have been found to promote wakefulness. To further appreciate this association, we gathered updated evidence of this novel therapeutic approach and compared it, evaluating its clinical use in an acute stroke setting. We carried out a systematic review of clinical trials conducted exclusively on stroke patients who received levodopa. Four clinical trials were reviewed and analyzed after applying the inclusion/exclusion criteria. The use of levodopa showed positive results in four of the clinical trials, and statistically significant results in 3/4 of the studies; however, more studies need to be conducted to corroborate these results.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138904PMC
http://dx.doi.org/10.7759/cureus.24529DOI Listing

Publication Analysis

Top Keywords

clinical trials
12
systematic review
8
stroke patients
8
levodopa
4
levodopa stroke
4
stroke systematic
4
stroke
4
review stroke
4
stroke leading
4
leading death
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!